Ambalal Sarabhai Enterprises Ltd. benchmarking: Performance to industry peers

Financial

	Ambalal Sarabhai Ent	Lyka Labs	Coral Laboratories
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	0.01 %	n/a	n/a
Financials
5 yr Average ROE	19.11 %	68.98 %	8.16 %
5yr average Equity Multiplier	2.07	2.9	1.18
5yr Average Asset Turnover Ratio	0.75	0.73	0.47
5yr Avg Net Profit Margin	10.89 %	-0.79 %	14.82 %
Price to Book	1.52	2.71	1.07
P/E	13.56	0.0	13.65
5yr Avg Cash Conversion Cycle	-37.53 Days	32.55 Days	35.5 Days
Inventory Days	33.51 Days	24.2 Days	69.25 Days
Days Receivable	63.69 Days	92.33 Days	98.13 Days
Days Payable	147.98 Days	106.74 Days	131.4 Days
5yr Average Interest Coverage Ratio	9.88	2.2	171.88
5yr Avg ROCE	24.01 %	25.83 %	10.48 %
5yr Avg Operating Profit Margin	5.29 %	24.02 %	14.88 %
5 yr average Debt to Equity	0.32	1.25	0.02
5yr CAGR Net Profit	-30.01 %	n/a	12.26 %
5yr Average Return on Assets	8.69 %	1.72 %	6.95 %
Shareholdings
Promoter Holding	31.36 %	58.16 %	71.51 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.59 %	7.16 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	-3.3 %	0.0

	Ambalal Sarabhai Ent	Lyka Labs	Coral Laboratories
Product Wise Break-Up	Product Wise Break-Up Electronics 53.67 Pharmaceutical 46.33 Formulations 0 Bulk Drugs 0 Formulation of Medicine 0	Product Wise Break-Up Bulk Drugs 3.2 Pharmaceutical 0 Formulations 96.8 Formulation of Medicine 0 Electronics 0	Product Wise Break-Up Bulk Drugs 0 Pharmaceutical 0 Formulations 0 Formulations 100.0 Electronics 0
Location Wise Break-Up	Location Wise Break-Up India 64.56 Rest of the World 35.44 International 0 Domestic 0 Ethiopia 0	Location Wise Break-Up Ethiopia 0 India 63.48 International 36.52 Rest of the World 0 India 0	Location Wise Break-Up Ethiopia 21.5 Domestic 0 International 0 Rest of the World 57.87 India 19.05 Others 1.58
Operating Profit Break-Up	Operating Profit Break-Up Electronics 51.4 Pharmaceuticals 48.6	-	-
Capex	Capex Pharmaceuticals 57.12 Electronics 42.88	-	-
Asset Break-Up	Asset Break-Up Pharmaceuticals 73.71 Electronics 26.29	-	-